Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
That is just an initial valuation by them. If you read the whole nanyang news, they still have not considered many factors into the pricing. By the way, the price will increase from time to time due to increase demand for pharmacological supplements sold by Bioalpha amid the large amount of covid cases. Initial evaluation of topglov was just a few bugs, look where it is now. Moreover, a 5 year contract had been signed.
That is a huge gross profit considering Bioalpha as a health supplement company. By the way, China's demand for this supplement will increase too due to the coronavirus. Hmmmmm